Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.51 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.49 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.49 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.48 |
| ▸ | STING1 | Q86WV6 | 5/20 | 0.48 |
| ▸ | TGM2 | P21980 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HINT1 | P49773 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.46 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.46 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.46 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.46 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.46 |
| ▸ | PNP | P00491 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2218829 | 0.90 | HPGD (0.57) | NT5ETAS1R3TAS1R1FUT5TGM2 | |
| SCHEMBL21344309 | 0.90 | NT5E (0.55) | NT5ETAS1R3TAS1R1FUT5TGM2 | |
| SCHEMBL888070 | 0.90 | HPGD (0.57) | NT5ETAS1R3TAS1R1FUT5TGM2 | |
| SCHEMBL1299533 | 0.89 | NT5E (0.58) | NT5ETAS1R3TAS1R1FUT5STING1 | |
| SCHEMBL1299520 | 0.89 | NT5E (0.58) | NT5ETAS1R3TAS1R1FUT5STING1 | |
| SCHEMBL17438077 | 0.86 | HPGD (0.57) | NT5ETAS1R3TAS1R1FUT5TGM2 | |
| SCHEMBL17461707 | 0.83 | NT5E (0.54) | NT5ETAS1R3TAS1R1FUT5TGM2 | |
| SCHEMBL15832464 | 0.83 | HPGD (0.56) | NT5ETAS1R3TAS1R1FUT5TGM2 | |
| SCHEMBL12590073 | 0.83 | NT5E (0.53) | NT5ETAS1R3TAS1R1FUT5TGM2 | |
| SCHEMBL33190 | 0.83 | NT5E (0.53) | NT5ETAS1R3TAS1R1FUT5TGM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120020252-A | SiRNA for inhibiting LPA expression and application thereof | 纳肽得(青岛)生物医药有限公司 | 2025-05-20 | — | — | CN | disclosed |
| CN-120005877-A | SiRNA for inhibiting expression of complement factor B and application thereof | 纳肽得(青岛)生物医药有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-120005876-A | SiRNA for inhibiting expression of angiotensinogen and application thereof | 纳肽得(青岛)生物医药有限公司 | 2025-05-16 | — | — | CN | disclosed |